Is this the SkinnyJab?
In short, yes. This is the commonly reffered to "SkinnyJab" in newspapers, articles & by pharmacies, though we do not own the trademarked brand name. We prefer a holistic and personal approach, so we branched off to create our own company.
So what is our Unique Selling Point? Well for starters, we have not just one but two qualified nutritionists on the team. We have a qualified personal trainer to offer professional exercise advice, several nurses who supervise the medical side of things and even some of our clients who have now come to work for us.
We're not about the hard sales; we are about your weight loss journey.
Our team has a mix of skills, with qualifications in NHS healthcare, nutrition, personal training and holistic wellbeing, and personal experience with weight loss.
Do you offer the Weekly Jab?
Yes we do. After careful consideration and following the current clinical trials and various other studies closely, we have taken the decision to offer the latest weekly jab. We must be clear with you - it is NOT licensed for weight loss at the moment, however it is in Phase 3 of clinical trials for weight loss and has so far shown to be highly effective for weight loss and improving the cardiovascular system. You may have seen the progress reported in the news in February 2021 regarding Semaglutide. Please see the Daily and Weekly SkinnyJab pages for the differences.
How do they work?
Produced by Novo Nordisk, the medication mimics a natural hormone already found in your body (GLP-1). It works in three key ways to reduce your appetite.
It blocks a key hunger hormone telling your brain that you are hungry, whilst also helping to reduce leptin resistance (a hormone which can help off-set weight gain by increasing satiety aka fullness, and speed up your metabolism to help regulate the levels of fatty tissue in your body). This also helps stop the weight from coming straight back on when you stop the jab.
It slows down the gastric emptying process, meaning that your body takes longer to process food and it is fuller for longer. This means your body does not need as much intake as normal as it works off the food it has.
The medication helps to speed up your metabolism and increase fat burning by reducing glucogen & reducing insulin resistance. This promotes normal blood glucose levels, the liver metabolism of glucose and helps adipose tissue burn fat in a safe and controlled method without causing a sugar-crash. This avoids the urges for quick-fix sugary foods.
This all helps to reduce the risk of the so-called "starvation mode" and other side effects like ketoacidosis, as you will be burning off a mixture of stored carbs & fats.
Unlike fad diets which tend to starve the body when it's shouting out for food, the medication reduces your body's desire to get more food, which makes it easier to make healthier choices and to reduce calories. It also stops leptin levels from rising due to "starvation". Low leptin levels can cause increased hunger & a slower metabolism!
This means that when you stop using the medication, the body isn't desperate for sustenance and therefore, you won't suddenly begin storing fat and gain all the weight back. Ironically, it's a more natural way to lose the weight and keep it off.
For further clinical information & data, please see the Novo Nordisk website.
What is included?
Your health screening & consultation.
Your medicated pen (jab) with needles with aftercare literature.
Dietary & nutritional advice from our in-house qualified nutritionists.
4 Week Meal Guide + 4 Week Metabolism Boosting Meal Guide
Exercise advice from our in-house Personal Trainer.
Access to our online Members Area for recipes, healthy swaps & tips.
Unlimited aftercare from our team if you need some advice or guidance.
Regular check-ins from our team to ensure you are getting the best out of your pen.
2 Types of Jabs:
Frequently Asked Questions:
How much can I expect to lose?
The average weight loss per person is always different. Clinical trials for all 3 types of the medication have shown a range of weight loss between 8lbs and 19lbs.
In the latest Semaglutide study released in February 2021, 75% of participants lost 10% of their body weight. During clinical trials for Liraglutide, 80% of those who used Saxenda kept the weight for over a year.
The key is not to compare yourself to others losing weight - focus on yourself, your goals and your progress. Every person is different.
How do I start the programme?
This is a prescription-only medication and it must be prescribed ensure your safety & suitability. There are three simple steps:
Screening: we send you a health screening form by email to ensure your safety & suitability.
Consultation: if all is well, we conduct a consultation via telephone, with the option to FaceTime at the end.
Make an informed chouce: if you are happy with all the information provided and you wish to go ahead, payment is made & the medication is dispatched to you.
During the consultation, we assess your medical history, explore your eating habits & exercise levels, and look at your goals. We also explore your reasoning behind wanting to use medication to help you lose weight.
We will invoice you via a secure payment provider so you can pay securely online. Once payment is received, your pen will be dispatched for next working day delivery if ordered by 1pm.
Our delivery schedule is currently up to 3 working days
due to the recent increase in demand. Thank you
for your patience.
Who are the jabs suitable for?
The programme is suitable for the vast majority of people. Our team will assess you on an individual basis.
The medication can be used for those who are overweight but our clinicians take into account a range of factors to ensure this is the right move for you.
We look at several factors to ensure suitability, including:
Your medical history
Your current medication
Current diet & eating habits
Current exercise levels
Other methods you have already tried
The programme is NOT suitable for:
Ladies who are breastfeeding or pregnant or actively trying to get pregnant.
Anyone who has had pancreatitis or thyroid tumours
Type 1 diabetics or patients taking diabetic medication